Thinking of psoriasis and atopic dermatitis as a spectrum, rather than separate diseases might lead to better understanding, and potentially better treatments.
Until recently, atopic dermatitis treatments were primarily limited to topical corticosteroids and systemic immunosuppressants.
Now, two new therapies have reached clinical practice. Nineteen more are in development.
Early trial results show a significant reduction of itch with the oral NK-1 antagonist serlopitant
Dupilumab plus topical corticosteroids safe and effective after failure of cyclosporine in moderate-to-severe atopic dermatitis
Metabolomics could provide new statistical methods to help monitor psoriasis disease and progression.
New Orleans - Several effective methods for fixing liposuction defects are available, but surgeons doing primary liposuction procedures should try to avoid the risk of overcorrection in the first place by removing fat conservatively, according to Lisa M. Donofrio, M.D.
Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
Chicago - Escalating doses of an antibody to CTLA-4 in conjunction with a peptide vaccine showed the induction of antigen-specific immune responses and potential evidence of autoimmunity in patients with stage III/IV resected melanoma, according to Jeffrey M. Weber, M.D., Ph.D.
Miami Beach, Fla. -Fewer than one in five parents of children attending a dermatology or pediatrics clinic knew that tanning devices provide only limited sunburn protection, recent survey results show.
New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.